How Pharmaceutical Companies Prepare for FDA Questions on Extractables and Leachables (E&L) Data
Understanding the Regulatory Landscape of FDA Questions on E&L Studies The Food and Drug Administration (FDA) carefully evaluates extractables and […]
Insulin Analog Characterization for Generic ANDA: Peptide Mapping, Sequencing, and Sameness Strategy
Introduction: Insulin analog characterization for generic ANDA is one of the most scientifically demanding challenges in the follow-on biologics space.
Higher-Order Structure (HOS) Characterization of Therapeutic Peptides: Methods and Regulatory Expectations
Introduction: Higher-order structure characterization of therapeutic peptides is no longer optional science — it is a regulatory and scientific imperative.
How Long Does Nitrosamine Testing Take? Realistic Timelines by Study Type
Maintaining a predictable Nitrosamine Testing Timeline has become a critical operational requirement for pharmaceutical manufacturers working to meet stringent compliance
How Long Does Nitrosamine Testing Take? Realistic Timelines by Study Type Read More »
Role of Surfactants and Emulsifiers in PLGA Microsphere Fabrication by Double Emulsion
Introduction to Interfacial Dynamics of Surfactants and Emulsifiers in PLGA Microsphere Fabrication The primary function of surfactants and emulsifiers in
Role of Surfactants and Emulsifiers in PLGA Microsphere Fabrication by Double Emulsion Read More »
Forced Degradation and Stress Testing of Therapeutic Peptide APIs: ICH Q1A-Aligned Strategy
ICH Q1A-Aligned Strategy for Forced Degradation and Stress Testing An ICH Q1A-aligned strategy for forced degradation and stress testing of
Peptide Aggregation Analysis: SEC-MALS, DLS, and AUC for Detecting Aggregated Species
Introduction: The Critical Role of Peptide Aggregation Analysis in Biopharmaceutical Quality Peptide Aggregation Analysis is a critical regulatory and biophysical
Peptide Aggregation Analysis: SEC-MALS, DLS, and AUC for Detecting Aggregated Species Read More »
Best Practices for Toxicological Qualification of Leachables
Introduction to the Advanced Landscape of Toxicological Qualification of Leachables The toxicological qualification of leachables is a critical process that
Best Practices for Toxicological Qualification of Leachables Read More »
Naltrexone PLGA Microsphere Case Study: Controlling Burst Release Through Polymer Design
Introduction: Naltrexone PLGA microsphere burst release is one of the most technically demanding problems in long-acting injectable (LAI) formulation science.
Naltrexone PLGA Microsphere Case Study: Controlling Burst Release Through Polymer Design Read More »
Nitrosamine Analytical Method Development and Validation Services: From LOQ to Full GMP Validation
Introduction: Why Conventional Analytical Methods Are Insufficient for Nitrosamines For pharmaceutical manufacturers facing increasing regulatory scrutiny regarding genotoxic impurities, conventional